Loading clinical trials...
Loading clinical trials...
A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, B...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Chicago
NCT06018766 · Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction, and more
NCT02181257 · Bronchiolitis Obliterans Syndrome (BOS)
NCT05413356 · Bronchiolitis Obliterans Syndrome, Hematologic Malignancy
NCT02863835 · Transplantation, Heart-Lung, Chronic Lung Allograft Dysfunction, and more
NCT01009619 · Bronchiolitis Obliterans Syndrome, Graft Rejection, and more
The University of Chicago Medical Center
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions